FAM84A | Family with sequence similarity 84, member A | | | | | | Tissue enhanced |
FER1L6 | Fer-1-like 6 (C. elegans) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXD2 | Forkhead box D2 | Transcription factors
| | | | | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FRMD1 | FERM domain containing 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
FUT2 | Fucosyltransferase 2 (secretor status included) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD3 | FXYD domain containing ion transport regulator 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GAL3ST1 | Galactose-3-O-sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | Enzymes
| | | | | Tissue enhanced |
GALNT6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GCNT1 | Glucosaminyl (N-acetyl) transferase 1, core 2 | Enzymes
| | | | | Tissue enhanced |
GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin type | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GHRH | Growth hormone releasing hormone | Predicted secreted proteins
| | | | | Tissue enhanced |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLOD5 | Glyoxalase domain containing 5 | | | | | | Tissue enhanced |
GNAT3 | Guanine nucleotide binding protein, alpha transducing 3 | | | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | RAS pathway related proteins
| | | | | Tissue enhanced |
GPR128 | G protein-coupled receptor 128 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR142 | G protein-coupled receptor 142 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR35 | G protein-coupled receptor 35 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HAP1 | Huntingtin-associated protein 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
HAPLN4 | Hyaluronan and proteoglycan link protein 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
HAVCR1 | Hepatitis A virus cellular receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HEPACAM2 | HEPACAM family member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HIST1H2BH | Histone cluster 1, H2bh | | | | | | Tissue enhanced |
HKDC1 | Hexokinase domain containing 1 | Enzymes
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HNF4G | Hepatocyte nuclear factor 4, gamma | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HOXB9 | Homeobox B9 | Transcription factors
| | | | | Tissue enhanced |
HOXD12 | Homeobox D12 | Transcription factors
| | | | | Tissue enhanced |
HPDL | 4-hydroxyphenylpyruvate dioxygenase-like | | | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | | | | | | Tissue enhanced |
INSM1 | Insulinoma-associated 1 | Transcription factors
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK10 | Potassium channel, subfamily K, member 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
KIAA1658 | | | | | | | Tissue enhanced |